Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
China biopharma investing was the major theme...
GenePharma, a young and growing private company in...
WuXi PhamaTech released positive Q1 results though...
Japan-based Daiichi Sankyo will buy a majority stake in...
ChinaBio® Today looked at the newest draft of the...
Perhaps this is the adolescent phase of China biopharma...
Covering the BioBay Investor Forum 2008, Interfax...
PriceWaterhouseCoopers asks a really big question: which...
Phynova will adopt a China-centric business plan; Crown...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
